New developments in the management of malaria in adults
|
|
- Lorraine McDonald
- 6 years ago
- Views:
Transcription
1 Q J Med 2009; 102: doi: /qjmed/hcp087 Advance Access Publication 5 August 2009 Review New developments in the management of malaria in adults J.K. ROE and G. PASVOL From the Department of Infection & Tropical Medicine, Imperial College London, Lister Unit Northwick Park Hospital, Harrow, Middlesex HA1 3UJ, UK Summary In dealing with malaria, the challenge that remains is prompt diagnosis and initiation of specific and supportive treatment. Physicians should be aware of the therapeutic and prognostic implications of life-threatening falciparum vs. non-falciparum malaria and be able to at least recognize the severe manifestations of malaria which may require Introduction There are up to 2000 cases of malaria and deaths in the UK each year, making malaria the single-most common imported infection among travelers. 1 These figures may seem trivial when set against the global scale of disease, reflected in the two worlds of malaria i.e. in travelers and those living in endemic areas. 2 Globally, two billion people living in endemic areas are at risk; up to 250 million clinical cases occur each year and over 1 million die, largely infants and young children in Africa. 3 However, it is essential in this age of rapid and easy international travel that practicing clinicians are at least aware of when to suspect, and also how to diagnose malaria; detailed specialist advice can then always be sought. A missed diagnosis can have fatal consequences. Advances in our understanding of the pathogenesis of the disease, the emergence of drug resistance 4,5 and the availability of new anti-malarial drugs have influenced changes that have occurred in clinical management over an increased level of care or referral to a specialist unit. The most important new developments in managing malaria in patients are the increasing problem of drug resistance, the availability of new antimalarial agents (most notably the artemisinins) and general advances in the management of any acutely ill patient in critical care. recent years and justify the need of this article at this time. Epidemiology Wherever temperatures are favorable (exceeding the 168C isotherm) and humans and the relevant Anopheles spp. mosquito vectors co-exist, there is potential for malarial transmission. Five species of malaria parasites are now known to affect humans and differ in their geographic distribution; Plasmodium falciparum most common in sub- Saharan Africa and Melanesia (Papua New Guinea and the Solomon Islands); P. vivax found mainly in Central and South America, North Africa, the Middle East and within the Indian subcontinent; P. ovale found almost exclusively in West Africa; P. malariae occurring worldwide, although mainly in Africa and finally P. knowlesi, recently documented on the island of Borneo and other parts of Southeast Asia. 6 Address correspondence to Prof. G. Pasvol, Department of Infection & Tropical Medicine, Imperial College London, Lister Unit, Northwick Park Hospital, Harrow, Middlesex HA1 3UJ, UK. g.pasvol@imperial.ac.uk! The Author Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please journals.permissions@oxfordjournals.org
2 686 J.K. Roe and G. Pasvol Table 1 Manifestations of severe falciparum malaria 8 Manifestation Cerebral malaria Respiratory distress Hypoglycemia Circulatory collapse (shock) Bleeding Renal involvement and blackwater fever Severe anemia Impaired consciousness of any degree, prostration, jaundice, intractable vomiting, parasitemia 2% Comment Unrousable coma (GCS < 11/15), with peripheral P. falciparum parasitemia after exclusion of other causes of encephalopathy Pulmonary edema or acute respiratory distress syndrome Whole blood glucose <2.2 mmol/l (40 mg/dl) Systolic blood pressure <70 mmhg or core-skin temperature difference >108C Spontaneous bleeding and/or laboratory evidence of disseminated intravascular coagulation (DIC) Urine output of less than 400 ml in 24 h (or <12 ml/kg in children) and a serum creatinine >265mmol/l (>3.0 mg/dl). Dark, black colored urine Normocytic anemia with hemoglobin <5 g/dl (hematocrit <15%) in presence of parasitemia >10 000/ml Previously unexposed individuals with any of these manifestations should be managed as severe i.e. with parenteral antimalarials Pathogenesis The clinical symptoms and signs of malaria are produced solely by the asexual forms in the blood which invade and destroy red cells, localize in critical organs and tissues in the body, obstruct the microcirculation and release putative toxins which induce the release of many proinflammatory cytokines leading to the classical malarial rigor. 7 Clinical features The most frequent presentation of malaria is that of a pronounced febrile illness. However, the clinical features can be extremely diverse. Mild malaria The incubation period for malaria is variable, but under optimal conditions may be as short as 7 days and in exceptional cases up to 20 years, as in the case of P. malariae infections. The majority (>90%) of P. falciparum infections in travelers occur within 6 weeks of leaving an endemic area. The presentation of malaria with a paroxysm including rigors is well known. There is usually a history of travel to or residence within an endemic area. Compliance with the most effective antimalarial chemoprophylaxis cannot exclude the diagnosis. There may be a prodromal period of tiredness and aching. The features of a classical rigor of malaria are an abrupt onset of an initial cold stage associated with dramatic shaking followed by an ensuing hot stage with temperatures often over 408C, during which there may be restlessness, excitability, vomiting or even convulsions. Finally, there is the sweating stage, with a fall in temperature and sometimes drowsiness. Such a paroxysm may last 6 10 h and a prolonged asymptomatic period may follow, lasting h in the case of P. vivax and P. ovale infections and h in P. malariae infections. In P. knowlesi infections the cycle occurs at each 24 h; in P. falciparum the periodicity of fever tends to be less predictable and the fever may be continuous due to the asynchrony of parasite development. Headache, cough, myalgia (flu-like symptoms), diarrhea and mild jaundice are nonspecific symptoms of all malarias, whereas lymphadenopathy, pharyngitis or a rash are atypical and require an alternative explanation. Examination of a patient with mild malaria may reveal a fever, tachycardia and little else. Severe malaria Definitions of the clinical manifestations of severe malaria are for the standardization of clinical studies rather than clinical care and must therefore be taken in context (Table 1). 8 However, these must be recognized early. For example, any degree of impairment of consciousness, prostration, jaundice, evidence of renal impairment, repeated vomiting or a parasitemia of >2% especially in non-immune individuals, should be taken seriously and treated with parenteral rather than oral antimalarials. 9 In USA, this threshold is set higher at 5% parasitemia, 10 but in our study of 482 patients with falciparum malaria, any patient with a parasitemia >2% was at distinct risk of WHO case-definition severe disease. 11
3 Management of malaria in adults 687 number of pathologies, each requiring different clinical interventions. Tachypnea may be the result of respiratory compensation for a profound metabolic acidosis as occurs in the majority of cases, or perhaps the result of secondary lung infection due to the immunosuppression that may accompany acute disease. Pulmonary edema leading to rapid respiration may be the consequence of hypoalbuminemia, iatrogenic fluid overload or direct alveolar capillary damage produced by parasites and neutrophils leading to vascular occlusion and the acute respiratory distress syndrome (ARDS). 14 Air hunger could also be the result of severe anemia. Figure 1. Fundus photograph displaying malarial retinopathy consisting of multiple white centered hemorrhages, macular whitening (arrowheads) and orange discoloration of vessels (arrow). Figure taken from PLoS ONE. 12 Pregnant women are particularly at risk for severe disease especially hypoglycemia. Cerebral malaria In cerebral malaria the patient passes from drowsiness to coma insidiously over a few days or abruptly within 1 2 h often heralded by a convulsion. The majority have no focal neurologic signs, but occasionally cranial nerve palsies, monoplegia or hemiplegia, extensor posturing, decerebrate or decorticate rigidity, conjugate or even dysconjugate eye movements, grinding of the teeth (bruxism) or hiccoughs may occur. Some patients have typical retinal hemorrhages 12 (Figure 1). Coma in malaria may not only be due to primary neurologic involvement (i.e. classical cerebral malaria), but may also be part of a prolonged post-ictal state or status epilepticus (especially in children) or a severe metabolic disorder such as acidosis or hypoglycemia, each requiring a different modality of management. Respiratory distress Respiratory distress is manifest by rapid labored breathing sometimes abnormal in rhythm 13. In children there may be intercostal recession, use of the accessory muscles and flaring of the alar nasae, making it difficult to differentiate from an acute respiratory infection. As with coma, respiratory distress in patients with malaria may be the result of a Acidosis Acidosis (base excess <12mmol/l) or acidemia (ph < 7.3) in malaria indicates a poor prognosis and may be the result of number of causes: poor tissue perfusion, in some cases due to hypovolemia, leading to reduced oxygen delivery; lactate production by the parasite; lactate generation as a result of cytokine activity, especially TNF, in the acute phase response; reduced hepatic blood flow and therefore lactate clearance; impaired renal function and therefore acid excretion; and exogenous acids due to aspirin (salicylate) administration. Hypoglycemia The characteristic clinical manifestations of hypoglycemia may not be evident in malaria, often because the patient is already unconscious. Suspicion of this important complication is often circumstantial: on admission in children and during quinine therapy in adults, especially if pregnant. 15 The cause of hypoglycemia is most likely multifactorial due to depletion of glucose stores because of starvation or malnutrition, malabsorption of glucose due to decreased splanchnic blood flow, increased tissue metabolism of glucose, parasite utilization of glucose, cytokine-induced impairment of gluconeogenesis and hyperinsulinemia due to quinine therapy. Anaerobic metabolism of glucose leads to acidemia and the production of lactate. Acidemia (ph < 7.3) and hyperlactatemia (lactate > 6mmol/l) are indicators of a poor prognosis. Circulatory collapse (shock) Unlike in the sepsis syndrome, shock is relatively rare in severe malaria. In most cases the blood pressure of patients with malaria is at the lower end of the normal range, probably a result of vasodilatation and hypovolemia. Marked hypotension in a few cases may be the result of dehydration, but is
4 688 J.K. Roe and G. Pasvol more commonly due to concomitant sepsis. 16 Sepsis frequently arises from the respiratory and urinary tracts. Bleeding Despite the frequent presence of thrombocytopenia, most likely the result of diffuse sequestration of platelets, 17 overt evidence of bleeding is rare in malaria. Bleeding is more likely to occur in the setting of disseminated intravascular coagulation (DIC). However, more often there is only subtle activation of the coagulation cascade with a reduction in antithrombin III concentration, an increase in thrombin antithrombin III complexes and a reduction in factor XII and prekallikrein activities, which do not appear to be clinically significant. 18 Renal involvement and blackwater fever A degree of renal impairment (often due to hypovolemia, but not always clinically evident), almost always occurs in severe malaria. Acute renal failure, which is less common, may occur in malaria both during the acute parasitemic phase, but also after parasite clearance. In addition acute renal failure in malaria may be nonoliguric. Although the urinary manifestation of blackwater fever may be dramatic, sometimes occurring in the setting of glucose- 6-phosphate dehydrogenase (G6PD) deficiency or a semi-immune patient given quinine, it does not invariably lead to renal failure and appears to be considerably more benign than the classically described syndrome. 19 Hyponatremia is probably the reflection of hypovolemia and is often self correcting and paradoxically associated with a better outcome. 20 Severe anemia The anemia of falciparum malaria is both complex and multifactorial. The fall in hemoglobin is often far in excess of what can be accounted for by the loss of infected red blood cells alone and by inference must therefore include uninfected cells. Major mechanisms in the pathogenesis of anemia in acute infection are those of red cell lysis by parasites, removal of uninfected cells due to antibody sensitization or other physicochemical changes as a result of increased reticuloendothelial activity particularly in organs such as the spleen. Differential diagnosis Malaria must be considered in all patients with fever or a history of fever who have visited a malaria endemic country. A travel history should now be a routine part of any consultation of a patient with a fever. Malaria is a great mimic and must enter the differential diagnosis of a number of clinical presentations. Fever due to malaria needs to be differentiated from typhoid, viral illnesses such as dengue fever and influenza, brucellosis and respiratory and urinary tract infections. Less common causes of tropical fevers include amoebic liver abscess, leishmaniasis, trypanosomiasis, rickettsial infections and relapsing fevers. The coma of cerebral malaria need to be differentiated from meningitis (including tuberculous meningitis), encephalitis, enteric fevers, trypanosomiasis, brain abscess and other causes of coma. The renal failure of malaria must be distinguished from renal impairment due to massive intravascular hemolysis seen in G6PD deficiency, sickle cell disease, leptospirosis, snake envenomation, use of traditional herbal medicines and chronic renal disease resulting from glomerulonephritis and hypertension. The jaundice and hepatomegaly of malaria must be distinguished from that of viral hepatitis (A, B and E, cytomegalovirus and Epstein Barr virus infections), leptospirosis, yellow fever, biliary disease and drug-induced disease including alcohol. The anemia of malaria can be confused with other common causes of hemolytic anemia such as that due to the hemoglobinopathies (e.g. sickle cell disease, thalassemia), G6PD deficiency and must be differentiated from that of iron, folate or vitamin B12 deficiency. Diagnosis Blood films The definitive diagnosis of malaria is made by prompt microscopic examination of thick and thin blood films. There is no need to wait for a fever peak before carrying out a blood film. In addition to the presence or absence of parasites, the species and parasite density can be determined from the blood film. Furthermore in falciparum malaria, other helpful information, often suggestive of a poorer prognosis, may be present on the film such as mature trophozoite forms, the presence of schizonts or excessive malarial pigment present in neutrophils or macrophages observed in some but not all studies. 21 Other methods Malaria can be diagnosed using other methods, but each has its own drawbacks with regard to time, cost, or being non-quantitative or non-specific.
5 Management of malaria in adults 689 Table 2 Treatment of non-falciparum malaria Drug Dose Comment Chloroquine phosphate or sulfate (each tablet contains 150 mg base) Followed in ovale malaria by primaquine Followed in vivax malaria by increased dose of primaquine Loading dose 600 mg, 300 mg 6 h later, then 300 mg daily for 2 days (i.e. 10 tablets in all) Infrequently chloroquine resistance occurs requiring atovaquone and proguanil, quinine plus doxycycline or mefloquine treatment 15 mg daily for 14 days Not given in G6PD deficiency or 45 mg weekly for 6 weeks with monitoring for hemolysis in the presence of mild G6PD deficiency. Not given in pregnancy 30 mg daily for 14 days Not given in G6PD deficiency or 45 mg weekly for 6 weeks with monitoring for hemolysis in the presence of mild G6PD deficiency. Not given in pregnancy Rapid diagnostic tests (RDTs) based on antigen capture, using a monoclonal antibody to the histidine-rich protein 2 of P. falciparum or parasite lactate dehydrogenase (pldh) of P falciparum or P. vivax. They are useful in patients who have not had malaria before. RDTs require minimal expertise, but are expensive and are not quantitative. 22 The polymerase chain reaction (PCR) is useful for making an accurate species diagnosis and detecting low level parasitemias, but its expense, time taken and requirement for specialized equipment make it impractical. Treatment Once a definitive diagnosis of malaria has been made the mainstay of treatment is the administration of specific and appropriate antimalarials. 9 Non-falciparum malaria Malaria due to P. vivax, P. ovale, P. malariae or P. knowlesi requires a standard course of treatment with chloroquine, which usually leads to defervescence (Table 2). In resistant cases of P. vivax, atovaquone and proguanil, or quinine plus tetracycline, or mefloquine as for falciparum malaria can be used. 10 In the case of P. vivax and P. ovale, malaria treatment with an 8-aminoquinoline (primaquine) is given to eradicate the exoerythrocytic forms, hypnozoites responsible for relapses. Levels of G6PD should be measured in all patients before they are given primaquine (see Table 2). Falciparum malaria Mild falciparum malaria Increasing resistance to chloroquine and pyrimethamine with sulfadoxine (Fansidar Õ ) worldwide make these drugs obsolete for the treatment of falciparum malaria. A range of treatments are available depending on affordability, cost and choice of local practice (Table 3). There is increasing use of drug combinations such as atovaquone with proguanil (Malarone Õ ) 23 and artemether with lumefantrine (Riamet Õ ), 24 which are better tolerated than quinine. Mefloquine (Lariam Õ ) may also be used. Whichever drug is used, parasitemia may paradoxically rise in the first h and is not generally indicative of treatment failure. Quinine requires treatment to be followed up by a second agent to prevent recrudescence. Severe falciparum malaria The management of severe falciparum malaria constitutes a medical emergency. The diagnosis needs to be confirmed microscopically and intravenous access obtained as soon as possible. Patients with severe malaria should be transferred to the highest possible level of clinical care (e.g. a highdependency or intensive therapy unit). Extra vigilance needs to be observed in pregnancy but apart from caution if artesunate is to be used, the avoidance of doxycycline and a lower threshold for exchange transfusion, the management is no different. Measurement of glucose, and where possible, lactate and arterial blood gases, should be performed in the initial assessment. Meticulous care must be given to fluid balance as both dehydration and overhydration can occur as a result of the disease or treatment. An effective antimalarial, ideally artesunate, should be given intravenously (Table 4). Artesunate has distinct advantages over quinine in its effectiveness and toxicity profile. In a large randomized trial, artesunate resulted in a 35% absolute reduction in mortality. 25 Unfortunately, artesunate is not as yet manufactured to good manufacturing practice (GMP), and hence does not have a product
6 690 J.K. Roe and G. Pasvol Table 3 Treatment of mild falciparum malaria Drug Dose Comments Quinine sulfate 10 mg (salt)/kg (usually 600 mg) 8 hourly for 3 7 days. (At a practical level when parasite clearance has been achieved for 24 h) Almost all patients develop cinchonism (ringing in the ears, deafness, nausea, vomiting, etc.) and especially if they have liver or renal impairment reduce dose to twice daily if parasite count falling. Followed by: Doxycycline or 200 mg daily for 7 days Not for children or in pregnancy Clindamycin 450 mg three times a day orally for 7 days Can be used for pregnant women and in children at the appropriate dose Atovaquone and proguanil (Malarone Õ ) Artemether and lumefantrine (Riamet Õ ) Four tablets daily for three days (each tablet contains atovaquone 250 mg and proguanil 100 mg) If weight >35 kg, four tablets at 8, 24, 36 and 60 h Better tolerated than quinine. Main side effects are gastrointestinal. Relatively few side effects Mefloquine (Lariam Õ ) 750 mg as a single dose, repeated after 6 h Contraindicated in early pregnancy and in patients with neuropsychiatric history licence in Europe or Food and Drug Administration approval in the USA but can be used on a named patient basis where available in the UK and via an investigational-new-drug (IND) application from the Centre for Disease Control and Prevention (CDC) in the USA. 26 Information on the use of artesunate in the treatment of severe malaria in pregnancy is limited. 25 Blood should be taken for cross-matching and coagulation studies. Before parenteral therapy with quinine, a baseline electrocardiogram should be obtained with careful observation of the rhythm and QT interval in elderly patients, particularly those with underlying heart disease, and where possible a cardiac monitor should be set up. Blood and exchange transfusion Blood transfusion may be of benefit in patients who have respiratory distress and metabolic acidosis. In units with appropriate facilities, complicated hyperparasitemia may be treated with exchange transfusion. 27 The use of exchange transfusion is controversial, but should be considered where safe blood is available for all patients in whom the parasitemia exceeds an arbitrary 30% and for those in whom parasitemia is lower, but who: (i) have manifestations of severe complicated malaria (ii) have underlying medical complaints, such as diabetes mellitus and ischemic heart disease, (iii) are elderly, or (iv) are pregnant. 28 During the course of treatment useful parameters for monitoring progress should include twice-daily parasite counts, regular ph and blood gas measurements and appropriate measurement of glucose and lactate concentrations and renal function. Each patient needs to be assessed individually. During quinine infusion it is essential to monitor blood glucose carefully. Elective ventilation needs to be considered where facilities are available, especially if there is severe acidosis, clear evidence of raised intracranial pressure or respiratory failure of any cause. Cerebral malaria Antimalarials form the mainstay of treatment for cerebral malaria. A number of adjuvant therapies such as corticosteroids and heparin have been tried, but have not been shown to be effective. Some children and a few adults show evidence of raised intracranial pressure, in which case a therapeutic trial of an osmotic agent such as mannitol may be attempted. Acute renal failure Dialysis or hemofiltration may be required. The indications are similar to those for any other form of renal failure. Nonoliguric renal failure may be managed conservatively.
7 Management of malaria in adults 691 Table 4 Antimalarial treatment regimens in severe falciparum malaria Drug Dose Comments Artesunate 2.4 mg/kg intravenously followed by 1.2 mg/kg at 12 and 24 h; then 1.2 mg/kg daily (usual adult dose 120 mg followed by doses of 60 mg daily for 6 days) each as a bolus until parasites cleared. Follow with doxycycline or clindamycin as for mild falciparum malaria (Table 3) Can be given intravenously as it is water soluble. Also requires a second agent (doxycycline or clindamycin) as recrudescences are common Quinine dihydrochloride 10 mg (salt) per kg by infusion over 4 h in 500 ml 5% dextrose, every 8 h until parasites less than 1% and the patient can take by mouth, then quinine sulfate 600 mg three times a day orally until parasites have cleared. Follow with doxycycline 200 mg daily orally for 7 days or clindamycin. A loading dose 20 mg over 4 h in 500 ml 5% dextrose should be given to young otherwise healthy patients and where hyperparasitemia cannot be treated by exchange transfusion Can induce hypoglycemia and cardiac arrhythmias. Special caution should be taken when used in the elderly and those with underlying cardiovascular disease. The loading dose should not be given to patients who have received quinine, quinidine or mefloquine in the previous 24 h Quinine dihydrochloride (rapid loading dose) Quinidine gluconate (in the USA where parenteral quinine is not available) 7 mg (salt) per kg by infusion pump over 30 min, followed immediately by 10 mg/kg over 4 h in 5% dextrose every 8 h until the parasitemia is less than 1% and the patient can take by mouth, then quinine sulfate 600 mg three times a day until parasites have cleared. Follow with doxycycline or clindamycin as with mild falciparum malaria (Table 3) 24 mg quinidine salt/kg (equivalent to 15 mg/kg base) infused over 4 h, followed by 12 mg/kg salt (7.5mg base) over 4 h every 8 hourly until parasites less than 1% and the patient can take by mouth, then quinine sulfate 600 mg three times a day until parasites have cleared. Follow with doxycycline or clindamycin as with mild falciparum malaria (Table 3) As above Quinidine gluconate (continuous infusion) 10 mg salt/kg (equivalent to 6.25 mg base/kg) infused over 2 h, followed by a continuous infusion of 0.02 mg salt/kg/min ( mg base/kg/min quinidine) until parasites <1% and the patient can take by mouth, then quinine sulfate 600 mg three times a day until parasites have cleared. Follow with doxycycline or clindamycin as with mild falciparum malaria (Table 3) Acidosis Adequate fluid replacement avoiding fluid overload is essential. Sodium bicarbonate has not been shown to be of any benefit and may worsen acidosis. Transfusion of anemic patients has been shown to improve severe acidosis and reduce lactate concentration in young children. Early hemodifiltration and ventilation may be used according to availability. The inotrope epinephrine (adrenaline) should be avoided unless absolutely necessary as it may worsen the acidosis, unlike dopamine, dobutamine and norepinephrine (noradrenaline). 29
8 692 J.K. Roe and G. Pasvol Bacterial superinfection Bacterial superinfection is common in malaria and must be suspected, particularly if the fever remains high despite antimalarial treatment or if there is evidence of focal sepsis (e.g. respiratory or urinary tract infection). Adjunctive therapies Many adjunctive therapies have been tried in malaria, but few, if any, have been shown to be of benefit. The use of anti-tnf antibodies has been disappointing and corticosteroids are clearly not indicated in the treatment of acute cerebral malaria. The role of iron chelators and heparin remains unresolved as does the use of an anti-tnf agent, pentoxifylline. The role of mannitol in patients who have evidence of raised intracranial pressure, dichloroacetate in patients who have hyperlactatemia and the free radical scavenger, desferroxamine, remains unclear. Conclusion Malaria in its uncomplicated form remains relatively easy to treat once the diagnosis is made. The challenge in complicated and severe disease is the rapid institution of appropriate antimalarials and the highest possible level of care. For severe falciparum malaria the current drug of choice is parenteral water-soluble artemisinin derivative, artesunate and failing that, the careful administration of parenteral quinine. A major current limitation is the availability of artesunate, not yet manufactured to good manufacturing practice (GMP), and hence without a product licence in Europe or Food and Drug Administration Approval in the USA. Hopefully this shortcoming will be resolved in the very near future. Conflict of interest: None declared. References 1. Smith AD, Bradley DJ, Smith V, Blaze M, Behrens RH, Chiodini PL, et al. Imported malaria and high risk groups: observational study using UK surveillance data BMJ 2008; 337:a Wellems TE, Miller LH. Two worlds of malaria. N Engl J Med 2003; 349: Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005; 434: Ekland EH, Fidock DA. Advances in understanding the genetic basis of antimalarial drug resistance. Curr Opin Microbiol 2007; 10: Hyde JE. Drug-resistant malaria - an insight. FEBS J 2007; 274: Cox-Singh J, Davis TM, Lee KS, Shamsul SS, Matusop A, Ratnam S, et al. Plasmodium knowlesi malaria in humans is widely distributed and potentially life threatening. Clin Infect Dis 2008; 46: Pasvol G. Cell-cell interaction in the pathogenesis of severe falciparum malaria. Clin Med 2001; 1: WHO. Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg 2000;94 (Suppl. 1):S Lalloo DG, Shingadia D, Pasvol G, Chiodini PL, Whitty CJ, Beeching NJ, et al. UK malaria treatment guidelines. J Infect 2007; 54: Griffith KS, Lewis LS, Mali S, Parise ME. Treatment of malaria in the United States: a systematic review. JAMA 2007; 297: Phillips A, Bassett P, Zeki S, Newman S, Pasvol G. Risk factors for severe disease in adults with falciparum malaria. Clin Infect Dis 2009; 48: White VA, Lewallen S, Beare NA, Molyneux ME, Taylor TE. Retinal pathology of pediatric cerebral malaria in Malawi. PLoS ONE 2009; 4:e Marsh K, Forster D, Waruiru C, Mwangi I, Winstanley M, Marsh V, et al. Indicators of life-threatening malaria in African children. N Engl J Med 1995; 332: Maguire GP, Handojo T, Pain MC, Kenangalem E, Price RN, Tjitra E, et al. Lung injury in uncomplicated and severe falciparum malaria: a longitudinal study in papua, Indonesia. J Infect Dis 2005; 192: White NJ, Warrell DA, Chanthavanich P, Looareesuwan S, Warrell MJ, Krishna S, et al. Severe hypoglycemia and hyperinsulinemia in falciparum malaria. N Engl J Med 1983; 309: Berkley J, Mwarumba S, Bramham K, Lowe B, Marsh K. Bacteraemia complicating severe malaria in children. Trans R Soc Trop Med Hyg 1999; 93: Karanikas G, Zedwitz-Liebenstein K, Eidherr H, Schuetz M, Sauerman R, Dudczak R, et al. Platelet kinetics and scintigraphic imaging in thrombocytopenic malaria patients. Thromb Haemost 2004; 91: Clemens R, Pramoolsinsap C, Lorenz R, Pukrittayakamee S, Bock HL, White NJ. Activation of the coagulation cascade in severe falciparum malaria through the intrinsic pathway. Br J Haematol 1994; 87: Tran TH, Day NP, Ly VC, Nguyen TH, Pham PL, Nguyen HP, et al. Blackwater fever in southern Vietnam: a prospective descriptive study of 50 cases. Clin Infect Dis 1996; 23: Hanson J, Hossain A, Charunwatthana P, Hassan MU, Davis TM, Lam SW, et al. Hyponatremia in severe malaria: evidence for an appropriate anti-diuretic hormone response to hypovolemia. Am J Trop Med Hyg 2009; 80: Kremsner PG, Valim C, Missinou MA, Olola C, Krishna S, Issifou S, et al. Prognostic value of circulating pigmented cells in African children with malaria. J Infect Dis 2009; 199: Murray CK, Gasser RA Jr, Magill AJ, Miller RS. Update on rapid diagnostic testing for malaria. Clin Microbiol Rev 2008; 21:
9 Management of malaria in adults Krudsood S, Patel SN, Tangpukdee N, Thanachartwet W, Leowattana W, Pornpininworakij K, et al. Efficacy of atovaquone-proguanil for treatment of acute multidrug-resistant Plasmodium falciparum malaria in Thailand. Am J Trop Med Hyg 2007; 76: Hatz C, Soto J, Nothdurft HD, Zoller T, Weitzel T, Loutan L, et al. Treatment of acute uncomplicated falciparum malaria with artemether-lumefantrine in nonimmune populations: a safety, efficacy, and pharmacokinetic study. Am J Trop Med Hyg 2008; 78: Dondorp A, Nosten F, Stepniewska K, Day N, White N. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet 2005; 366: Rosenthal PJ. Artesunate for the treatment of severe falciparum malaria. N Engl J Med 2008; 358: Riddle MS, Jackson JL, Sanders JW, Blazes DL. Exchange transfusion as an adjunct therapy in severe Plasmodium falciparum malaria: a meta-analysis. Clin Infect Dis 2002; 34: Wilkinson RJ, Brown JL, Pasvol G, Chiodini PL, Davidson RN. Severe falciparum malaria: predicting the effect of exchange transfusion. Q J Med 1994; 87: Day NP, Phu NH, Mai NT, Bethell DB, Chau TT, Loc PP, et al. Effects of dopamine and epinephrine infusions on renal hemodynamics in severe malaria and severe sepsis. Crit Care Med 2000; 28:
The management of malaria in adults
Clinical Medicine 2011, Vol 11, No 5: 497 501 braziliensis cutaneous leishmaniasis. Br J Dermatol 2005;153:203 5. 17 Reithinger R, Dujardin JC, Louzir H et al. Cutaneous leishmaniasis. Lancet Infect Dis
More informationFACTS. Approximately 2.48 million malaria cases are reported annually from South Asia. Of Which 75% cases are contributed by India alone.
MALARIA 2 FACTS Approximately 2.48 million malaria cases are reported annually from South Asia. Of Which 75% cases are contributed by India alone. The magnitude of the problem is further enhanced by P
More informationMalaria. An Overview of Life-cycle, Morphology and Clinical Picture
Malaria An Overview of Life-cycle, Morphology and Clinical Picture Malaria Malaria is the most important of all tropical parasitic disease,causes death and debility and is endemic throughout the tropics
More informationMalaria parasites Malaria parasites are micro-organisms that belong to the genus Plasmodium. There are more than 100 species of Plasmodium, which can infect many animal species such as reptiles, birds,
More informationMalaria in Children. University Hospitals of Leicester NHS Trust Children's Services Medical Guidelines. Title: Malaria in children
Management of Malaria in Children Malaria is a febrile illness caused by Plasmodium falciparum, vivax, malariae, ovale and knowlesi.delayed diagnosis can be fatal and hence a high index of suspicion is
More informationAntimalarials in the WHO Essential Drugs List for Children Reviewer No.1
Antimalarials in the WHO Essential Drugs List for Children Reviewer No.1 Part I: Evaluation of the current list Proposed grouping from the March 2007 meeting 6.5.3 Antimalarial medicines 6.5.3.1 For curative
More informationDisclosure Information
Malaria Medications Charlie Mosler, RPh, PharmD, CGP, FASCP Assistant Professor of Pharmacy Practice The University of Findlay College of Pharmacy Findlay, OH mosler@findlay.edu Disclosure Information
More informationDEPARTMENT OF HEALTH AND HUMAN SERVICES CENTERS FOR DISEASE CONTROL AND PREVENTION SAFTER HEALTHIER PEOPLE TM
MALARIA TREATMENT GUIDELINES Treatment of Malaria (Guidelines For Clinicians) If you wish to share your clinical experience, please contact us at: nciddpdmalaria@cdc.gov Treatment Table The Treatment Table
More informationPARASITOLOGY CASE HISTORY #14 (BLOOD PARASITES) (Lynne S. Garcia)
PARASITOLOGY CASE HISTORY #14 (BLOOD PARASITES) (Lynne S. Garcia) A 37-year-old woman, who had traveled to New Guinea for several weeks, presented to the medical clinic with fever, chills, and rigors within
More informationMalaria Updates. Fe Esperanza Espino Department of Parasitology Research Institute for Tropical Medicine
Malaria Updates Fe Esperanza Espino Department of Parasitology Research Institute for Tropical Medicine Outline General epidemiology of malaria in the Philippines P falciparum Updates in treatment Recognizing
More informationDecember 2012 Critical Care Case of the Month: Sepsis-like Syndrome in a Returning Traveler. Eric Chase, MD Eric Ong, MD John Bloom, MD
December 2012 Critical Care Case of the Month: Sepsis-like Syndrome in a Returning Traveler Eric Chase, MD Eric Ong, MD John Bloom, MD University of Arizona Division of Pulmonary and Critical Care Medicine
More informationInvest in the future, defeat malaria
Invest in the future, defeat malaria Malaria is caused by parasites from the genus Plasmodium, which are spread to people by infected mosquitoes. There are five species of Plasmodium that can infect humans.
More informationDirectorate of National Vector Borne Disease Control Programme
NATIONAL DRUG POLICY ON MALARIA (2008) Directorate of National Vector Borne Disease Control Programme (Directorate General of Health Services) Ministry of Health and Family Welfare 22-Shamnath Marg,, Delhi-110054..
More informationA comparative clinical trial of artemether and quinine in Cerebral Malaria
Original Article A comparative clinical trial of artemether and quinine in Cerebral Malaria Sheraz Jamal Khan, Syed Munib From Department of Medicine, Gomal Medical College, Dera Ismail Khan Correspondance:
More informationSustained funding is crucial to malaria control
Update on Malaria Chi Eziefula Senior Lecturer in Brighton and Sussex Centre for Global Health Research, Brighton and Sussex Medical School Honorary Consultant in Infection, Brighton and Sussex University
More informationMalaria Bad Air. Sarah K. Parker, MD Associate Professor of Pediatrics and Pediatric Infectious Diseases
Malaria Bad Air Sarah K. Parker, MD Associate Professor of Pediatrics and Pediatric Infectious Diseases Malaria: Lecture Goals Understand basic principles of malaria pathogenesis in the context of relevance
More informationA COMPARATIVE STUDY OF QUININE V/S ARTESUNATE IN SEVERE MALARIA PATIENTS IN NORTHWESTERN RAJASTHAN, INDIA
A COMPARATIVE STUDY OF QUININE V/S ARTESUNATE IN SEVERE MALARIA PATIENTS IN NORTHWESTERN RAJASTHAN, INDIA K. C. Nayak, Rakesh Meena, *Surendra Kumar, B. K. Gupta, V. B. Singh and Varun Kulkarni Department
More informationMalaria. is a mosquito-born disease causing about 3 million deaths a year world-wide. Many are children under the age of 5.
Malaria is a mosquito-born disease causing about 3 million deaths a year world-wide. Many are children under the age of 5. The parasite is transmitted by bites from the female anopheles mosquito. Currently,
More information38 Current Concepts in
38 Current Concepts in Management of Falciparum Malaria Abstract: Artemisinin based Combination Therapy (ACT) is the preferred agent to treat drug resistance uncomplicated Plasmodium Falciparum (PF) Malaria.
More informationEVEN THOUGH ENDEMIC MALARIA
CLINICAL REVIEW CLINICIAN S CORNER Treatment of Malaria in the United States A Systematic Review Kevin S. Griffith, MD, MPH Linda S. Lewis, DVM, MPVM Sonja Mali, MPH Monica E. Parise, MD EVEN THOUGH ENDEMIC
More informationMALARIA CASE STUDY. Major Chris Carter Defence School of Healthcare Education, Department of Healthcare Education Birmingham City University
MALARIA CASE STUDY Major Chris Carter Defence School of Healthcare Education, Department of Healthcare Education Birmingham City University BACKGROUND Malaria is a parasitic infection caused by the genus
More informationCombination Anti-malarial Therapy and WHO Recommendations
Prakaykaew Charunwatthana 2, and Sasithon Pukrittayakamee 1,2 1 Associate Fellow of the Royal Institute, Academy of Science 2 Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol
More informationISSN X (Print) Original Research Article. DOI: /sjams India
DOI: 10.21276/sjams.2016.4.6.22 Scholars Journal of Applied Medical Sciences (SJAMS) Sch. J. App. Med. Sci., 2016; 4(6B):1981-198 5 Scholars Academic and Scientific Publisher (An International Publisher
More informationAnas Raed. - Zaid Emad. - Malik Zuhlof
- 6 - Anas Raed - Zaid Emad - Malik Zuhlof 1 P a g e - This lecture started with the excellent presentation of chronic fatigue syndrome and the role of Vitamin B12 in its treatment by our colleague Osama
More informationMODULE V. Management of Prevalent Infections in Children Following a Disaster
MODULE V Management of Prevalent Infections in Children Following a Disaster MAIN CAUSES OF DEATH Acute respiratory infections Diarrhea and dehydration Measles Malaria Malnutrition The IMCI strategy 2
More informationCASE IN... Acute Infectious Diseases. in the Returning Traveller. James Case. Acute Infectious Diseases
in the Returning Traveller Copyright CASE IN... Not for Sale or Commercial Distribution Unauthorised use prohibited. Authorised users can download, display, view and print a single copy for personal use
More informationRectal artesunate for pre-referral treatment of severe malaria
Global Malaria Programme Rectal artesunate for pre-referral treatment of severe malaria october 2017 information note Background Severe malaria is a medical emergency: mortality from untreated severe malaria
More informationMalaria and travellers health. Dr Behzad (Baz) Nadjm
Malaria and travellers health Dr Behzad (Baz) Nadjm Outline of talks Malaria 101 Developments in treatment Cases throughout Ms C M 30 Yr Old Arrived from Cameroon 2 weeks ago Forestry research Feeling
More informationUganda MALARIA: AN OVERVIEW Species Lifecycle of Plasmodium Exoerythrocytic (asymptomatic stage): Step 1: Step 2: Step 3:
Uganda MALARIA: AN OVERVIEW Compiled by Dr. Marelize Enslin Species Human malaria is a parasitic infection caused by different species of the plasmodium parasite:- Plasmodium falciparum - Causes >90% of
More informationUniversity of Veterinary and Animal Sciences, Bikaner), V.P.O. Bajor, Dist. Sikar, Rajasthan, India
REVIEW ARTICLE www.ijapc.com e-issn 2350-0204 Malaria, A Widely Prevalent Mosquito-Borne Infection in Humans and Recommended Herbal Therapy Subha Ganguly 1*, Satarupa Roy 2 1 Associate Department of Veterinary
More informationSymptoms of Malaria. Young children, pregnant women, immunosuppressed and elderly travellers are particularly at risk of severe malaria.
Preventing Malaria 1 Malaria is the world s most prevalent parasitic disease, accounting for an estimated 216 million cases with 655,000 deaths annually. Many people acquire malaria during travel to tropical
More informationScenario#1 Fever from Kenya. New Drugs for Malaria
New Drugs for Malaria This talk may be politically incorrect or in bad 1 taste.viewer discretion is advised 2 Scenario#1 Fever from Kenya A 37 year old traveller returns from a one month vacation in rural
More informationAlberta Health Public Health Notifiable Disease Management Guidelines July 2012
July 2012 Malaria Revision Dates Case Definition Reporting Requirements Remainder of the Guideline (i.e., Etiology to References sections inclusive) Case Definition Confirmed Case Laboratory confirmation
More informationMalaria. Edwin J. Asturias, MD
Malaria Edwin J. Asturias, MD Associate Professor of Pediatrics and Epidemiology Director for Latin America Center for Global Health, Colorado School of Public Health Global Health and Disasters Course
More informationAntimalarial Drugs. Munir Gharaibeh, MD, PhD, MHPE Department of Pharmacology Faculty of Medicine October 2014
Antimalarial Drugs Munir Gharaibeh, MD, PhD, MHPE Department of Pharmacology Faculty of Medicine October 2014 Malaria Annual Global Incidence: 219 million in 2010. Annually, in Africa, I million children
More informationAPPLICATION FOR REVISION AND INCLUSION OF MALARIA MEDICINES IN WHO MODEL LIST OF ESSENTIAL MEDICINES
APPLICATION FOR REVISION AND INCLUSION OF MALARIA MEDICINES IN WHO MODEL LIST OF ESSENTIAL MEDICINES The objective of this application is to assure compatibility between the WHO Model list of essential
More informationCerebral malaria in children
Cerebral malaria in children M. Chiara Stefanini Catholic University - Rome Malaria: epidemiology Global distribution of malaria transmission risk,, 2003 World malaria report, WHO, 2005 Estimated incidence
More informationMalaria. Population at Risk. Infectious Disease epidemiology BMTRY 713 (Lecture 23) Epidemiology of Malaria. April 6, Selassie AW (DPHS) 1
Infectious Disease Epidemiology BMTRY 713 (A. Selassie, DrPH) Lecture 23 Vector-Borne Disease (Part II) Epidemiology of Malaria Learning Objectives 1. Overview of malaria Global perspectives 2. Identify
More informationEvidence- Based Medicine Fluid Therapy
Evidence- Based Medicine Fluid Therapy Ndidi Musa M.D. Assosciate Professor of Pediatrics Medical College of Wisconsin/ Children s Hospital of Wisconsin Disclosures A. I have no relevant financial relationships
More informationLesson 6: Referal in severe and Complicated Malaria
Lesson 6: Referal in severe and Complicated Malaria From WikiEducator Contents 1 Introduction 1.1 Indications for Referral in Malaria 1.2 Criteria for Referral to Hospital 1.3 Management of Referred Patients
More informationOutcome of Severe Malaria in Endemic Zone - Study From a District Hospital of Bangladesh
Dr. Md. AMIR HOSSAIN Department of Medicine Rangamati General Hospital Deputed to BSMMU, Dhaka. Outcome of Severe Malaria in Endemic Zone - Study From a District Hospital of Bangladesh 1 INTRODUCTION In
More informationThe Malarias: Plasmodium falciparum Plasmodium vivax Plasmodium malariae Plasmodium ovale. Distribution of Plasmodium falciparum
The Malarias: Plasmodium falciparum Plasmodium vivax Plasmodium malariae Plasmodium ovale Distribution of Plasmodium falciparum 1 Distribution Of Plasmodium vivax 2 Global Risk By Country-Proportionality
More informationInterpretation of the World Malaria Report Country Profile
Interpretation of the World Malaria Report Country Profile Acknowledgements This presentation was developed to help explain the components of the World Malaria Report Country Profile. The 2017 World Malaria
More informationStudy No.: Title: Rationale: Phase: Study Period: Study Design: Centers: Indication: Treatment: Objective: Primary Outcome/Efficacy Variable:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationCLINICAL EXPERIENCE WITH INTRAVENOUS QUININE, INTRAMUSCULAR ARTEMETHER AND INTRAVENOUS ARTESUNATE FOR THE TREATMENT OF SEVERE MALARIA IN THAILAND
SOUTHEAST ASIAN J TROP MED PUBLIC HEALTH CLINICAL EXPERIENCE WITH INTRAVENOUS QUININE, INTRAMUSCULAR ARTEMETHER AND INTRAVENOUS ARTESUNATE FOR THE TREATMENT OF SEVERE MALARIA IN THAILAND Srivicha Krudsood
More informationSevere falciparum malaria with hypophosphataemia and presumed hypophosphatemia induced rhabdomyolysis: a case report
142 Case Report Severe falciparum malaria with hypophosphataemia and presumed hypophosphatemia induced rhabdomyolysis: a case report M Perera, V Samarawickrama, K Lokuketagoda, K Thirumavalavan Sri Lankan
More informationMODULE V. Management of Prevalent Infections in Children Following a Disaster
MODULE V Management of Prevalent Infections in Children Following a Disaster MODULE V Management of Common Childhood Illness Following a Disaster Infections FACTORS IMPACTING INFECTIONS IN DISASTER SITUATIONS
More informationStudy on admitted cases of complicated malaria in Government General Hospital, Guntur
Original article: Study on admitted cases of complicated malaria in Government General Hospital, Guntur 1Dr. T. V. Adi Seshu Babu, 2 Dr.Uday Shankar Sanakayala 1Associate professor, Department of General
More informationMalaria. benign (mild) malaria
Malaria Caused by the plasmodium protozoa. Four species of plasmodium causes human malaria: Plasmodium falciparum responsible for nearly all serious complications and deaths. P. vivax P. malariae P. ovale
More informationMalaria. Traveler Summary. Key Points. Introduction. Risk Areas
Malaria Traveler Summary Key Points Malaria is an infection caused by a parasite that lives within the red blood cells and is acquired through the bite of mosquitoes which generally feed at night. This
More informationIncrease in temperatures in Africa, rise in humidity creating new water sources and the start of agriculture in the Middle East and North East Africa
1 HISTORY 2 Malaria has been known to mankind for thousands of years. Increase in temperatures in Africa, rise in humidity creating new water sources and the start of agriculture in the Middle East and
More informationMALARIA & TRAVEL MEDICINE
MALARIA & TRAVEL MEDICINE Awadh R. Alanazi M.D King Saud University College Of Medicine 1440--2019 EDUCATIONAL OBJECTIVES At the end of this lecture students are expected to know: Epidemiology & Etiology.
More informationKath Maitland Imperial College London & KEMRI / Wellcome Trust Programme, Kilifi, Kenya
Severe malaria: management with few resources Kath Maitland Imperial College London & KEMRI / Wellcome Trust Programme, Kilifi, Kenya Plasmodium falciparum malaria In African children
More informationHot from the Tropics! Fever in the returned traveler workshop. UHN Conference 2015
Hot from the Tropics! Fever in the returned traveler workshop UHN Conference 2015 Case 1: General approach to fever in the returning traveller Exercise 1: Location of travel and pathogens 1. Focus on what
More information40% (90% (500 BC)
MALARIA causative agent = Plasmodium species 40% of world s population lives in endemic areas 3-500 million clinical cases per year 1.5-2.7 million deaths (90% Africa) known since antiquity early medical
More informationThe Malarias: Plasmodium falciparum Plasmodium vivax Plasmodium malariae Plasmodium ovale. Watersheds of the African Continent
The Malarias: Plasmodium falciparum Plasmodium vivax Plasmodium malariae Plasmodium ovale Global Risk By Country-Proportionality Plot P. falciparum P. vivax Distribution of Plasmodium falciparum 3 million
More informationClinical experience of 17 cases of imported malaria at a Taiwan university hospital,
J Microbiol Immunol Infect. 2007;40:209-215 Chung et al Original Article Clinical experience of 17 cases of imported malaria at a Taiwan university hospital, 1999-2005 Hsing-Chun Chung 1, Jann-Tay Wang
More informationMultiorgan Dysfunction in Plasmodium vivax Malaria: A Prospective Study
Original Article DOI: 10.17354/ijss/2015/366 Multiorgan Dysfunction in Plasmodium vivax Malaria: A Prospective Study Dilip R Patil 1, S D Nikumbh 2, Akhil Parulekar 2, Kedar Roplekar 2 1 Professor and
More informationLesson 3: Severe and Complicated Malaria
Lesson 3: Severe and Complicated Malaria From WikiEducator Contents 1 INTRODUCTION 2 what is Severe and Complicated Malaria? 3 Reflection 3.1 Pathophysiology of Severe Malaria 3.2 Diagnosis OF Severe Malaria
More informationIV Fluids. I.V. Fluid Osmolarity Composition 0.9% NaCL (Normal Saline Solution, NSS) Uses/Clinical Considerations
IV Fluids When administering IV fluids, the type and amount of fluid may influence patient outcomes. Make sure to understand the differences between fluid products and their effects. Crystalloids Crystalloid
More informationDocument Title: Communicable & Infectious Diseases Emergencies. Author(s): Katherine A. Perry (University of Michigan), RN, BSN 2012
Project: Ghana Emergency Medicine Collaborative Document Title: Communicable & Infectious Diseases Emergencies Author(s): Katherine A. Perry (University of Michigan), RN, BSN 2012 License: Unless otherwise
More informationNursing Process Focus: Patients Receiving Dextran 40 (Gentran 40)
Assess for presence/history of hypovolemia, shock, venous thrombosis. Assess vital signs: Hypovolemic shock secondary to surgery, burns, hemorrhage, other serious condition PT and PTT abnormalities Venous
More informationPRESCRIBING INFORMATION mg primaquine phosphate equivalent to 15 mg primaquine base. Antimalarial
PRESCRIBING INFORMATION Pr PRIMAQUINE primaquine phosphate tablets USP 26.3 mg primaquine phosphate equivalent to 15 mg primaquine base Antimalarial sanofi-aventis Canada Inc. 2150 St. Elzear Blvd. West
More informationElements for a public summary
VI.2 VI.2.1 Elements for a public summary Overview of disease epidemiology Malaria is caused by mosquito bites whereby the malaria parasites can enter the body and then live in body tissues such as red
More informationRisk Factors for Severe Disease in Adults with Falciparum Malaria
MAJOR ARTICLE Risk Factors for Severe Disease in Adults with Falciparum Malaria Anastasia Phillips, 1 Paul Bassett, 1 Sebastian Zeki, 1 Stanton Newman, 3 and Geoffrey Pasvol 1,2 1 Department of Infection
More informationPost Travel Fever. Dr. Eyal Leshem. Center for Geographic Medicine Sheba Medical Center Tel Hashomer, Israel
Post Travel Fever Dr. Eyal Leshem Center for Geographic Medicine Sheba Medical Center Tel Hashomer, Israel Introduction Fever in returned traveler: Trivial vs. life threatening infections Tropical and
More informationIn several African countries in sub-saharan Africa, malaria is the leading cause of death in children under five.
TECHNICAL SEMINAR - MALARIA SLIDE 1 Technical Seminar - Malaria Malaria is an extremely important cause of mortality in different parts of world. In this technical seminar, I ll discuss the rationale for
More informationExample Clinician Educational Material for Providers of Immune Effector Cellular Therapy
Example Clinician Educational Material for Providers of Immune Effector Cellular Therapy Disclaimer: This example is just one of many potential examples of clinician education material that can be provided
More informationACCEPTED. Diseases, Monash University, Commercial Road, Melbourne, Victoria 3004, Australia
The Pediatric Infectious Disease Journal Publish Ahead of Print DOI : 10.1097/INF.0000000000000671 Plasmodium vivax malaria: challenges in diagnosis, treatment, and elimination James G Beeson 1,2, Cindy
More informationTitle: Author: Benji Mathews. Date: 1/4/08. Key words: Malaria, Travel, Medications
Title: Author: Benji Mathews Date: 1/4/08 Key words: Malaria, Travel, Medications Abstract: Malaria is an insect borne disease widespread in tropical and subtropical regions of the world. It causes about
More informationMalaria: Prevention remains our best measure for controlling the disease
http://www.medicine-on-line.com Malaria: 1/10 Malaria: Prevention remains our best measure for controlling the disease Author: Supervisor: Affiliation: Naomi Cheng Professor Julia Ling The Chinese University
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Acute lymphoblastic leukemia, in India, 439 440 pediatric, global approach to, 420 424 core resources in low- and middle-income countries, 423
More informationMalaria Update Mark Polhemus Director, Center for Global Health and Translational Science
Malaria Update 2015 Mark Polhemus Director, Center for Global Health and Translational Science 97 countries with ongoing transmission 3.2 billion people at risk 584,000 deaths in 2013 77 studies with 46,000
More informationINVESTIGATION OF ADVERSE TRANSFUSION REACTIONS TABLE OF RECOMMENDED TESTS. Type of Reaction Presentation Recommended Tests Follow-up Tests
Minor Allergic (Urticarial) Urticaria, pruritis, flushing, rash If skin reaction only and mild hives/ rash
More informationTesting for G6PD deficiency for safe use of primaquine in radical cure of P. vivax and P. ovale
Testing for G6PD deficiency for safe use of primaquine in radical cure of P. vivax and P. ovale Webinar presentation to support the dissemination of the policy brief Silvia Schwarte, WHO/GMP e-mail: schwartes@who.int
More informationInternational Journal of Pharma and Bio Sciences A STUDY OF CLINCAL PROFILE IN DENGUE CASES ABSTRACT
Research Article Microbiology International Journal of Pharma and Bio Sciences ISSN 0975-6299 A STUDY OF CLINCAL PROFILE IN DENGUE CASES DHANDAPANI E.* 1 AND SUDHA M 2 1 Formerly Professor of Medicine,
More informationDOUBLE BLIND RANDOMISED CLINICAL TRIAL OF TWO DIFFERENT REGIMENS OF ORAL ARTESUNATE IN FALCIPARUM MALARIA
DOUBLE BLIND RANDOMISED CLINICAL TRIAL OF TWO DIFFERENT REGIMENS OF ORAL ARTESUNATE IN FALCIPARUM MALARIA Danai Bunnag, Chaisin Viravan, Sornchai Looareesuwan, Juntra Karbwang and T-ranakchit Harinasuta
More informationI. F. A. L. P. A. Malaria information for pilots. Briefing Leaflet. Medical. The Global Voice of Pilots
10MEDBL01 July 2009 Malaria information for pilots Executive Summary Malaria is a common and life-threatening disease in many tropical and subtropical countries. Malaria is transmitted to humans by the
More informationPediatric emergencies (SHOCK & COMA) Dr Mubarak Abdelrahman Assistant Professor Jazan University
Pediatric emergencies (SHOCK & COMA) Dr Mubarak Abdelrahman Assistant Professor Jazan University SHOCK Definition: Shock is a syndrome = inability to provide sufficient oxygenated blood to tissues. Oxygen
More informationCerebral Malaria Insights: Pathogenesis, Host Parasite Interactions including Host Resistance
Cerebral Malaria Insights: Pathogenesis, Host Parasite Interactions including Host Resistance By: Lydia Anikin, Marc Bacarro, Ashton Hurley, Nathan Graham, Alyssa MacLeod, Amelia Winczura: Oral presentation,
More informationSepsis Awareness and Education
Sepsis Awareness and Education Meets the updated New York State Department of Health (NYSDOH) requirements for Infection Control and Barrier Precautions coursework Element VII: Sepsis Awareness and Education
More informationSeptic Shock. Rontgene M. Solante, MD, FPCP,FPSMID
Septic Shock Rontgene M. Solante, MD, FPCP,FPSMID Learning Objectives Identify situations wherein high or low BP are hemodynamically significant Recognize complications arising from BP emergencies Manage
More informationImported malaria in children in the UK
76 Archives of Disease in Childhood 1997;77:76 81 CURRENT TOPIC Liverpool School of Tropical Medicine B J Brabin Y Ganley Correspondence to: Dr B J Brabin, Liverpool School of Tropical Medicine, Pembroke
More informationAnti-Malaria Chemotherapy
Anti-Malaria Chemotherapy Causal Prophylaxis prevent infection (ie, liver stage) Suppressive Prophylaxis prevent clinical disease (ie, blood stages) Treatment Therapy (or clinical cure) relieve symptoms
More informationComparison of clinical profile between Plasmodium vivax and Plasmodium falciparum malaria in children in tertiary care hospital
International Journal of Contemporary ediatrics Ravilala VK et al. Int J Contemp ediatr. 2018 Jul;5(4):1294-1299 http://www.ijpediatrics.com pissn 2349-3283 eissn 2349-3291 Original Research Article DOI:
More information14th Stakeholders Meeting
14th Stakeholders Meeting Steady progress towards malaria elimination: Interventions for today and tomorrow Denpasar, Bali 11 12 October 2017 David Hughes, Novartis 12th October 2017 Defeating Malaria
More informationL3-Malaria: Epidemiology, clinical management and control. 19 January 2018 SCBM346 TROPICAL INFECTIOUS DISEASES AND CONTROLS
19 January 2018 SCBM346 TROPICAL INFECTIOUS DISEASES AND CONTROLS L3-Malaria: Epidemiology, clinical management and control Lecturer: Niwat Kangwanrangsan, Ph.D. Department of Pathobiology Faculty of Science,
More informationIDELINES FO R THE TREATMENT OF MALARIA. Second edition
GU IDELINES FO R THE TREATMENT OF MALARIA Second edition Guidelines for the treatment of malaria Second edition Guidelines for the treatment of malaria 2 nd edition WHO Library Cataloguing-in-Publication
More informationClinical profile and outcome of severe P. Falciparum malaria
International Journal of Advances in Medicine Mundhe R et al. Int J Adv Med. 2016 Nov;3(4):1034-1038 http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20163744
More informationPARASITOLOGY CASE HISTORY #11 (BLOOD PARASITES) (Lynne S. Garcia)
PARASITOLOGY CASE HISTORY #11 (BLOOD PARASITES) (Lynne S. Garcia) A 39-year old male traveler developed fever and thrombocytopenia after returning from a trip to the Philippines. The parasitemia was 10,000
More informationCHAPTER 12 HYPERTENSION IN SPECIAL GROUPS HYPERTENSION IN PREGNANCY
CHAPTER 12 HYPERTENSION IN SPECIAL GROUPS HYPERTENSION IN PREGNANCY v Mild preeclampsia is managed by close observation of the mother and fetus preferably in hospital. If the diastolic blood pressure remains
More informationSituation update pandemic (H1N1) 2009
Situation update pandemic (H1N1) 2009 February 2010 USPACOM/COE Pandemic Influenza Workshop Overview Overview of Events Pandemic (H1N1) 2009 Issues/Concerns 2 Overview of events April 12: an outbreak of
More informationRisk Evaluation and Mitigation Strategy (REMS): Cytokine release syndrome and neurological toxicities
Risk Evaluation and Mitigation Strategy (REMS): Cytokine release syndrome and neurological toxicities A REMS is a program required by the FDA to manage known or potential serious risks associated with
More informationBox 1. Recommendations unchanged from the first edition of the Guidelines (2006)
Executive summary Executive Summary Malaria case management remains a vital component of the malaria control strategies. This entails early diagnosis and prompt treatment with effective antimalarial medicines.
More informationPrinted copies of this document may not be up to date, obtain the most recent version from
Children s Acute Transport Service Clinical Guidelines Septic Shock Document Control Information Author Claire Fraser P.Ramnarayan Author Position tanp CATS Consultant Document Owner E. Polke Document
More informationMONITORING THE THERAPEUTIC EFFICACY OF ANTIMALARIALS AGAINST UNCOMPLICATED FALCIPARUM MALARIA IN THAILAND
SOUTHEAST ASIAN J TROP MED PUBLIC HEALTH MONITORING THE THERAPEUTIC EFFICACY OF ANTIMALARIALS AGAINST UNCOMPLICATED FALCIPARUM MALARIA IN THAILAND C Rojanawatsirivej 1, S Vijaykadga 1, I Amklad 1, P Wilairatna
More informationINTRODUCTION. Dengue is one of the ten leading. Globally 20 million cases/yr. 24,000 deaths/yr. It is important to know the typical and atypical
DENGUE IN CHILDREN INTRODUCTION Dengue is one of the ten leading causes of hospitalization and death in children. Globally 20 million cases/yr. 24,000 deaths/yr. It is important to know the typical and
More informationIN VIVO EFFICACY AND SAFETY OF QUININE-DOXYCYCLINE COMBINATION IN ACUTE PLASMODIUM FALCIPARUM MALARIA
Original Article IN VIVO EFFICACY AND SAFETY OF QUININE-DOXYCYCLINE COMBINATION IN ACUTE PLASMODIUM FALCIPARUM MALARIA Abdul Rasheed 1, Shahzad Saeed 2 ABSTRACT Objective: To find out the in vivo efficacy
More informationKato, N. et al, Nature, 2016, Accelerated Article Preview. Celeste Alverez Current Literature 9/10/ /10/2016 Celeste Wipf Group 1
Kato, N. et al, Nature, 2016, Accelerated Article Preview Celeste Alverez Current Literature 9/10/2016 9/10/2016 Celeste Alverez @ Wipf Group 1 Malaria Caused by Plasmodium parasites Carried by 30-40 species
More informationPEDIATRIC INFLUENZA CLINICAL PRACTICE GUIDELINES
PEDIATRIC INFLUENZA CLINICAL PRACTICE GUIDELINES DEFINITIONS AND BACKGROUND Uncomplicated influenza illness is characterized by the abrupt onset of constitutional and respiratory signs and symptoms. Signs
More information